In this Newsletter:
Long-Term Stability of Primary Rat Hepatocytes in Micropatterned Cocultures
Okechukwu Ukairo, Michael McVay, Stacy Krzyzewski, Simon Aoyama, Kelly Rose, Melvin E. Andersen, Salman R. Khetani, Edward L. LeCluyse.
Journal of Biochemical and Molecular Toxicology. Early Release Epub, August 5, 2013. Read More
(August 6, 2013): Hepregen Corporation and the Hamner Institutes for Health Sciences Announce Research Partnership Agreement . Agreement Provides Opportunity to Collaborate on Research Supporting Next Generation In Vitro Micro-Liver Analysis Associated with Pharmaceutical and Chemical Product Development.
View press release
(August 5, 2013): Hepregen Corporation Announces Appointment of Dr. Michael Holsapple as Vice President of Toxicology Product Development. Appointment Adds Respected Leader in Toxicology to Hepregen's Senior Management Team, Reflecting Ongoing Commitment of Hepregen's Strategic Investor, Battelle Memorial Institute.
View press release
The Development & Validation of HepatoPac™, a Next Generation In Vitro Micro-liver Model
Learn about the next generation in vitro liver technology behind Hepregen's HepatoPacâ„¢ from the inventor of the micropatterning technology, Professor Sangeeta Bhatia of MIT. Discover how the increased predictive power of micropatterned hepatocyte co-cultures can revolutionize your toxicology and DMPK assays.
This webinar discusses: - Development of the innovative micropatterning technique
- Hepatocyte tissue organization and supportive cells interactions
- Engineering of micropatterned co-culture plates
- Extended longevity of hepatocyte viability and functionality using co-culture model
- Superior performance of co-cultures versus traditional models
- Hepregen platform of micropatterned co-cultures
For more information or to view this webinar
Expanded HepatoPac™ Kit Offering
Meeting up with Hegregen
10th Annual International ISSX Meeting
Sept. 29 -Oct 3, 2013
Toronto, Ontario, Canada
Visit us at Booth #211